Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Kalender
| 2020-05-29 | Bokslutskommuniké 2020 |
| 2020-02-21 | Halvårsutdelning EKTA B 0.90 SEK |
| 2020-02-20 | Kvartalsrapport 2020-Q3 |
| 2019-11-28 | Kvartalsrapport 2020-Q2 |
| 2019-08-23 | Halvårsutdelning EKTA B 0.90 SEK |
| 2019-08-22 | Årsstämma 2019 |
| 2019-08-22 | Kvartalsrapport 2020-Q1 |
| 2019-05-29 | Bokslutskommuniké 2019 |
| 2019-03-01 | Halvårsutdelning EKTA B 0.70 SEK |
| 2019-02-22 | Kvartalsrapport 2019-Q3 |
| 2018-11-29 | Kvartalsrapport 2019-Q2 |
| 2018-08-31 | Halvårsutdelning EKTA B 0.70 SEK |
| 2018-08-30 | Årsstämma 2018 |
| 2018-08-30 | Kvartalsrapport 2019-Q1 |
| 2018-06-01 | Bokslutskommuniké 2018 |
| 2018-03-02 | Kvartalsrapport 2018-Q3 |
| 2018-02-22 | Halvårsutdelning EKTA B 0.50 SEK |
| 2017-11-30 | Kvartalsrapport 2018-Q2 |
| 2017-08-24 | Halvårsutdelning EKTA B 0.50 SEK |
| 2017-08-23 | Kvartalsrapport 2018-Q1 |
| 2017-08-23 | Årsstämma 2017 |
| 2017-06-01 | Bokslutskommuniké 2017 |
| 2017-03-03 | Halvårsutdelning EKTA B 0.25 SEK |
| 2017-03-01 | Kvartalsrapport 2017-Q3 |
| 2016-12-01 | Kvartalsrapport 2017-Q2 |
| 2016-09-26 | Kapitalmarknadsdag 2016 |
| 2016-09-02 | Halvårsutdelning EKTA B 0.25 SEK |
| 2016-09-01 | Kvartalsrapport 2017-Q1 |
| 2016-09-01 | Årsstämma 2016 |
| 2016-06-01 | Bokslutskommuniké 2016 |
| 2016-03-02 | Kvartalsrapport 2016-Q3 |
| 2015-12-03 | Kvartalsrapport 2016-Q2 |
| 2015-09-02 | Ordinarie utdelning EKTA B 0.50 SEK |
| 2015-09-01 | Årsstämma 2015 |
| 2015-09-01 | Kvartalsrapport 2016-Q1 |
| 2015-06-02 | Bokslutskommuniké 2015 |
| 2015-03-04 | Kvartalsrapport 2015-Q3 |
| 2014-11-27 | Kvartalsrapport 2015-Q2 |
| 2014-11-27 | Analytiker möte 2014 |
| 2014-09-15 | Kapitalmarknadsdag 2014 |
| 2014-08-29 | Ordinarie utdelning EKTA B 1.50 SEK |
| 2014-08-29 | Bonusutdelning EKTA B 0.50 SEK |
| 2014-08-28 | Kvartalsrapport 2015-Q1 |
| 2014-08-28 | Årsstämma 2014 |
| 2014-08-28 | Analytiker möte 2015 |
| 2014-05-28 | Bokslutskommuniké 2014 |
| 2014-05-28 | Analytiker möte 2014 |
| 2014-02-27 | Kvartalsrapport 2014-Q3 |
| 2013-12-04 | Kvartalsrapport 2014-Q2 |
| 2013-09-23 | Kapitalmarknadsdag 2013 |
| 2013-09-04 | Bonusutdelning EKTA B 0.50 SEK |
| 2013-09-04 | Ordinarie utdelning EKTA B 1.50 SEK |
| 2013-09-03 | Kvartalsrapport 2014-Q1 |
| 2013-09-03 | Årsstämma 2013 |
| 2013-06-05 | Analytiker möte 2013 |
| 2013-06-05 | Bokslutskommuniké 2013 |
| 2013-03-05 | Kvartalsrapport 2013-Q3 |
| 2013-03-05 | Extra Bolagsstämma 2013 |
| 2012-12-04 | Kvartalsrapport 2013-Q2 |
| 2012-10-29 | Kapitalmarknadsdag 2012 |
| 2012-09-12 | Split EKTA B 1:4 |
| 2012-09-05 | Ordinarie utdelning EKTA B 5.00 SEK |
| 2012-09-03 | Årsstämma 2012 |
| 2012-09-03 | Kvartalsrapport 2013-Q1 |
| 2012-06-05 | Bokslutskommuniké 2012 |
| 2012-06-05 | Analytiker möte 2012 |
| 2012-04-02 | Extra Bolagsstämma 2012 |
| 2012-03-05 | Kvartalsrapport 2012-Q3 |
| 2011-12-02 | Kvartalsrapport 2012-Q2 |
| 2011-09-14 | Ordinarie utdelning EKTA B 4.00 SEK |
| 2011-09-13 | Årsstämma 2011 |
| 2011-09-13 | Kvartalsrapport 2012-Q1 |
| 2011-06-09 | Bokslutskommuniké 2011 |
| 2011-03-08 | Kvartalsrapport 2011-Q3 |
| 2010-12-07 | Kvartalsrapport 2011-Q2 |
| 2010-09-22 | Ordinarie utdelning EKTA B 3.00 SEK |
| 2010-09-21 | Kvartalsrapport 2011-Q1 |
| 2010-06-09 | Bokslutskommuniké 2010 |
| 2010-03-10 | Kvartalsrapport 2009-Q3 |
| 2009-12-10 | Kvartalsrapport 2009-Q2 |
| 2009-09-16 | Ordinarie utdelning EKTA B 2.00 SEK |
| 2009-09-15 | Kvartalsrapport 2009-Q1 |
| 2009-09-15 | Årsstämma |
| 2008-09-19 | Ordinarie utdelning EKTA B 1.75 SEK |
| 2007-09-26 | Ordinarie utdelning EKTA B 1.00 SEK |
| 2006-09-21 | Ordinarie utdelning EKTA B 1.00 SEK |
| 2005-10-17 | Split EKTA B 1:3 |
| 2005-09-22 | Ordinarie utdelning EKTA B 6.60 SEK |
| 2004-09-22 | Ordinarie utdelning EKTA B 0.00 SEK |
| 2003-09-23 | Ordinarie utdelning EKTA B 0.00 SEK |
| 2002-10-01 | Ordinarie utdelning EKTA B 0.00 SEK |
| 2001-09-28 | Ordinarie utdelning EKTA B 0.00 SEK |
| 2000-10-02 | Ordinarie utdelning EKTA B 0.00 SEK |
| 1999-09-23 | Ordinarie utdelning EKTA B 0.00 SEK |
Elekta Infinity and Elekta Synergy systems to alleviate China's burden of cancer
GUANGZHOU, China, January 15, 2020 - Elekta (EKTA-B.ST) and HEDY Group of Guangzhou, China, recently signed an agreement for 10 linear accelerators (linacs) as well as Monaco[®] treatment planning, MOSAIQ[®] Oncology Information System and service for each of the linacs.
HEDY group is a renowned private comprehensive enterprise in China, with focus on IT, real estate and big health. The company plans to invest in oncology hospitals in 20 cities in the country and an investment agreement was signed with Elekta in December 2019 for 16 cities. Construction of five of these centers has been completed and are expected to be operational in 2020. The company plans to run 20 hospitals with a total of 30,000 beds by 2025.
Anming Gong, Elekta's Executive Vice President Region China, says the company is addressing the country's need for radiation therapy devices and personnel to operate them. "Since entering the Chinese market in 1982, Elekta has been committed to leading the innovation of precision radiotherapy technology, supporting China's medical reform, and training radiotherapy professionals for hospitals at all levels in the country. Our factory in Beijing is now Elekta's largest radiotherapy equipment production base outside of Europe and recently produced its 100th linac."
The Elekta linacs in this recent order represent two of the company's most sophisticated treatment platforms:- Elekta Infinity, a truly multifunctional device, using advanced technology to offer a wide range of techniques for different indications.
- Elekta Synergy, which allows clinics with increasingly challenging access to capital and resources to deliver high quality, high volume treatments.
Elekta is the market leader in China and the region reported a revenue growth rate of 20 percent in Elekta's latest interim report.
# # #
For further information, please contact:
Oskar Bosson, Global EVP Corporate Communications and Public Affairs
Tel: +46 70 410 7180, e-mail: Oskar.Bosson@elekta.com
Time zone: CET: Central European Time
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CET: Central European Time
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com (http://www.elekta.com) or follow @Elektaon Twitter.